|
Oxaliplatin (125 mg) |
61825-94-3 |
1481204 |
USP |
詳細を見る
|
|
Oxaliplatin Related Compound A (100 mg) (Ethanedioic acid, dihydrate) |
6153-56-6 |
1481215 |
USP |
詳細を見る
|
|
Oxaliplatin Related Compound B (15 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanedia… |
66900-68-3 |
1481226 |
USP |
詳細を見る
|
|
Orlistat Related Compound D Solution (2 x 1 mL (5 mg/mL)) ((3S,4R,6S)-3-Hexyl-2… |
130793-27-0 |
1478877 |
USP |
詳細を見る
|
|
Orlistat Related Compound E (10 mg) (N-Formyl (S)-isoleucine (S)-1-[[(2S,3S)-3-… |
1072902-75-0 |
1478855 |
USP |
詳細を見る
|
|
Orphenadrine Citrate (200 mg) |
4682-36-4 |
1479009 |
USP |
詳細を見る
|
|
Orphenadrine Related Compound A (50 mg) ((RS)-N,N-dimethyl-2-[(3-methylphenyl)-… |
N/A |
1479010 |
USP |
詳細を見る
|
|
Ondansetron Related Compound C (30 mg) (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol… |
27387-31-1 |
1478618 |
USP |
詳細を見る
|
|
Ondansetron Related Compound D (30 mg) (1,2,3,9-Tetrahydro-9-methyl-3-methylene… |
99614-64-9 |
1478629 |
USP |
詳細を見る
|
|
Ondansetron Resolution Mixture (50 mg) |
N/A |
1478630 |
USP |
詳細を見る
|
